Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roncalli

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 1998
Cell cycle-related gene abnormalities and product expression in esophageal carcinomaM Roncalli, S Bosari, A Marchetti, et al.
The American Journal of Surgical Pathology|June 8, 2000
Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesionsG Martignoni, M Pea, G Rigaud, et al.
Placenta|June 1, 1994
C-myc and tumour suppressor gene product expression in developing and term human trophoblastM Roncalli, G Bulfamante, G Viale, et al.
Molecular Pathology : MP|August 26, 1998
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosisM Borzio, D Trerè, F Borzio, et al.
British Journal of Cancer|June 10, 2004
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancerH S Parra, R Cavina, F Latteri, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 1992
Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implicationsM Roncalli, C Doglioni, D R Springall, et al.
The Prostate|February 18, 1998
Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapyG Pruneri, S Galli, R S Rossi, et al.
American Journal of Respiratory Cell and Molecular Biology|January 1, 1991
Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lungA Giaid, J M Polak, V Gaitonde, et al.
British Journal of Cancer|September 14, 2006
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancerE Miranda, A Destro, A Malesci, et al.
International Journal of Cancer|December 18, 2001
Molecular disorders in transitional vs. peripheral zone prostate adenocarcinomaP Colombo, C Patriarca, R M Alfano, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 1998
Cell cycle-related gene abnormalities and product expression in esophageal carcinomaM Roncalli, S Bosari, A Marchetti, et al.
The American Journal of Surgical Pathology|June 8, 2000
Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesionsG Martignoni, M Pea, G Rigaud, et al.
Placenta|June 1, 1994
C-myc and tumour suppressor gene product expression in developing and term human trophoblastM Roncalli, G Bulfamante, G Viale, et al.
Molecular Pathology : MP|August 26, 1998
Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosisM Borzio, D Trerè, F Borzio, et al.
British Journal of Cancer|June 10, 2004
Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancerH S Parra, R Cavina, F Latteri, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|June 1, 1992
Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implicationsM Roncalli, C Doglioni, D R Springall, et al.
The Prostate|February 18, 1998
Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapyG Pruneri, S Galli, R S Rossi, et al.
American Journal of Respiratory Cell and Molecular Biology|January 1, 1991
Distribution of endothelin-like immunoreactivity and mRNA in the developing and adult human lungA Giaid, J M Polak, V Gaitonde, et al.
British Journal of Cancer|September 14, 2006
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancerE Miranda, A Destro, A Malesci, et al.
International Journal of Cancer|December 18, 2001
Molecular disorders in transitional vs. peripheral zone prostate adenocarcinomaP Colombo, C Patriarca, R M Alfano, et al.
Pageof 8